Want to see SG:8K7 full AI Analyst Report?
Top Page
UG Healthcare Corp. Ltd.
(SGX:8K7)
Select Model
Select Model
Rating:57Neutral
Price Target:
S$0.08
▼(-19.00% Downside)
Action:Reiterated
Date:08/29/26
The score is driven primarily by improving financial performance (return to profitability and positive free cash flow) and a generally sound balance sheet with moderate leverage. Offsetting this, profitability and returns remain low and historically volatile, while technical signals are mixed with the price still below longer-term moving averages. Valuation (P/E ~22.94) is not especially compelling given current margin/ROE levels, and no dividend yield data is available to provide additional support.
Positive Factors
Profitability Recovery
The return to profitability and higher gross margin indicate improved pricing, product economics, or cost control. Sustaining these gains would strengthen the core PPE business and provide a more durable base for future cash generation.
Negative Factors
Thin Profitability and Low Returns
Although earnings recovered, thin margins and very low ROE show that the business is not yet converting revenue or equity into strong returns. Limited profitability leaves less protection against pricing pressure, input-cost increases, or weaker demand.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
The return to profitability and higher gross margin indicate improved pricing, product economics, or cost control. Sustaining these gains would strengthen the core PPE business and provide a more durable base for future cash generation.
Read all positive factors
UG Healthcare Corp. Ltd. (8K7) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$48.03M
Dividend YieldN/A
Average Volume (3M)173.35K
Price to Earnings (P/E)21.5
Beta (1Y)0.56
Revenue Growth4.69%
EPS GrowthN/A
CountrySG
Employees837
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)N/A
Shares Outstanding623,825,800
10 Day Avg. Volume337,080
30 Day Avg. Volume173,353
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)0.28
Price to Sales (P/S)0.32
P/FCF Ratio3.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UG Healthcare Corp. Ltd. Business Overview & Revenue Model
Company Description
UG Healthcare Corporation Limited, an investment holding company established in Singapore in 1989, primarily engages in the manufacturing and worldwide distribution of disposable gloves. Its business is structured across three main segments: Latex...
UG Healthcare Corp. Ltd. Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
72
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.93M | 150.82M | 144.07M | 115.20M | 101.13M | 232.60M |
| Gross Profit | 3.43M | 42.87M | 34.74M | 25.87M | 1.45M | 84.39M |
| EBITDA | -21.20M | 11.41M | 2.47M | -3.94M | -23.97M | 53.37M |
| Net Income | -20.93M | 2.10M | -3.79M | -6.06M | -20.73M | 36.80M |
Balance Sheet | ||||||
| Total Assets | 215.39M | 240.52M | 232.35M | 226.45M | 230.00M | 288.04M |
| Cash, Cash Equivalents and Short-Term Investments | 45.13M | 27.41M | 23.29M | 28.00M | 61.74M | 100.22M |
| Total Debt | 28.46M | 40.52M | 47.36M | 43.72M | 31.13M | 17.98M |
| Total Liabilities | 44.08M | 70.75M | 76.03M | 65.17M | 48.81M | 52.98M |
| Stockholders Equity | 171.94M | 171.76M | 158.73M | 163.39M | 180.84M | 228.90M |
Cash Flow | ||||||
| Free Cash Flow | -36.98M | 14.97M | -8.11M | -20.71M | -47.17M | 31.63M |
| Operating Cash Flow | -34.35M | 17.59M | -4.78M | -18.16M | -39.14M | 53.95M |
| Investing Cash Flow | -2.63M | -2.62M | -3.21M | -22.73M | -8.03M | -21.19M |
| Financing Cash Flow | 4.62M | -11.20M | 3.24M | 8.36M | 8.70M | -973.00K |
UG Healthcare Corp. Ltd. Technical Analysis
Positive
0.10
Price Trends
0.08
Positive
0.08
Negative
0.09
Negative
Market Momentum
>-0.01
Negative
53.08
Neutral
54.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:8K7, the sentiment is Positive. The current price of 0.1 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.08, and above the 200-day MA of 0.09, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 53.08 is Neutral, neither overbought nor oversold. The STOCH value of 54.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:8K7.
UG Healthcare Corp. Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:8K7
UG Healthcare Corp. Ltd.
0.07
-0.03
-29.81%
SG:1J5
Hyphens Pharma International Ltd.
0.36
0.03
10.77%
SG:505
Asiamedic Limited
0.02
0.00
0.00%
SG:546
Medtecs International Corporation Ltd.
0.12
>-0.01
-4.72%
SG:MIJ
Alliance Healthcare Group Ltd.
0.18
0.05
39.53%
SG:OTX
Medinex Ltd.
0.23
0.03
14.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.